The Minnesota Department of Health (MDH) continues to conduct a voluntary survey of prospective Minnesota patients.
One week remains before the survey closes on Feb. 6 for patients to participate and help develop a clear picture of the scope and nature of demand for medical cannabis.
The survey asks potential medical cannabis patients several questions designed to provide program planners with more information such as patients' qualifying conditions, likelihood of participating in the program, and location in the state. It can be accessed at https://survey.vovici.com/se.ashx?s=56206EE350A5519C from Jan. 20 to Feb. 6. The MDH invites any Minnesotans with potentially qualifying conditions to participate. The list of qualifying conditions under state law includes:
• cancer with severe/chronic pain.
• cancer with nausea or severe vomiting.
ADVERTISEMENT
• cancer with cachexia or severe wasting.
• glaucoma.
• HIV/AIDS.
• Tourette's syndrome.
• amyotrophic lateral sclerosis (ALS).
• seizures, including those characteristic of epilepsy.
• severe and persistent muscle spasms, including those characteristic of multiple sclerosis.
• terminal illness (life expectancy of less than one year) with severe/chronic pain.
ADVERTISEMENT
• terminal illness (life expectancy of less than one year) with nausea or severe vomiting.
• terminal illness (life expectancy of less than one year) with cachexia or severe wasting.
The health department received nearly 700 responses so far and is hoping for a sample as large and representative as possible.
The Minnesota Department of Health's Office of Medical Cannabis is on track to provide medical cannabis products to patients by the statutory deadline of July 1, 2015. For more information about the medical cannabis program, visit the MDH medical cannabis website at www.health.state.mn.us/topics/cannabis/index.html.
